Synergy and other interactions in phytomedicines

被引:667
作者
Williamson, EM [1 ]
机构
[1] Univ London, Sch Pharm, London WC1N 1AX, England
关键词
synergy; phytomedicine; herbal interactions;
D O I
10.1078/0944-7113-00060
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Synergistic interactions are of vital importance in phytomedicines, to explain difficulties in always isolating a single active ingredient, and explain the efficacy of apparently low doses of active constituents in a herbal product. This concept, that a whole or partially purified extract of a plant offers advantages over a single isolated ingredient, also underpins the philosophy of herbal medicine. Evidence to support the occurrence of synergy in within phytomedicines is now accumulating and is reviewed here. Synergistic interactions are documented for constituents within a total extract of a single herb, as well as between different herbs in a formulation. Positive and negative aspects of interactions are discussed together with the methods used to identify and measure synergy. The evidence is divided into experimental, in vitro instances, as well as clinical examples where available. Herbs discussed include Ginkgo biloba, Piper methysticum (Kava-Kava), Glycyrrhiza glabra, Hypericum perforatum, Valeriana officinalis, Cannabis sativa, Salix alba and others.
引用
收藏
页码:401 / 409
页数:9
相关论文
共 35 条
[1]   Cannabinoids control spasticity and tremor in a multiple sclerosis model [J].
Baker, D ;
Pryce, G ;
Croxford, JL ;
Brown, P ;
Pertwee, RG ;
Huffman, JW ;
Layward, L .
NATURE, 2000, 404 (6773) :84-87
[2]  
BECKSTROMSTERNB.SM, 1994, SPICES HERBS EDIBLE, P210
[3]  
BERENBAUM MC, 1989, PHARMACOL REV, V41, P93
[4]   PLANT-DERIVED METABOLITES WITH SYNERGISTIC ANTIOXIDANT ACTIVITY [J].
BEUKELMAN, CJ ;
VANDENBERG, AJJ ;
KROES, BH ;
LABADIE, RP ;
MATTSSON, EE ;
VANDIJK, H .
IMMUNOLOGY TODAY, 1995, 16 (02) :108-108
[5]   INTERACTION OF LICORICE ON GLYCYRRHIZIN PHARMACOKINETICS [J].
CANTELLIFORTI, G ;
MAFFEI, F ;
HRELIA, P ;
BUGAMELLI, F ;
BERNARDI, M ;
DINTINO, P ;
MARANESI, M ;
RAGGI, MA .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 :65-68
[6]  
CHUNG KF, 1987, LANCET, V1, P248
[7]  
Duke J.A., 1999, NATURAL PRODUCTS PLA, P183
[8]  
ERNST E, 1999, HERBAL MED CONCISE O, P69
[9]  
Gaddum J.H., 1940, Pharmacology
[10]   Inhibition of 5 alpha-reductase and aromatase by PHL-00801 (Prostatonin(R)), a combination of PY 102 (Pygeum africanum) and UR102 (Urtica dioica) extracts [J].
Hartmann, RW ;
Mark, M ;
Soldati, F .
PHYTOMEDICINE, 1996, 3 (02) :121-128